![Corrigendum to “Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects”: Molecular Therapy Corrigendum to “Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects”: Molecular Therapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2082859076/2072954682/fx1.jpg)
Corrigendum to “Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects”: Molecular Therapy
![PDF) Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change PDF) Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change](https://i1.rgstatic.net/publication/340470486_Allogeneic_Hematopoietic_Cell_Transplantation_in_Patients_With_Aplastic_Anemia_and_Paroxysmal_Nocturnal_Hemoglobinuria_Clones_Time_for_a_Change/links/5e9f1e36299bf13079b1cb20/largepreview.png)
PDF) Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
![Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine](https://www.frontiersin.org/files/MyHome%20Article%20Library/608165/608165_Thumb_400.jpg)
Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine
![Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download](https://slideplayer.com/90/14522484/big_thumb.jpg)
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download
![Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation - Gavriilaki - 2018 - Clinical Transplantation - Wiley Online Library Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation - Gavriilaki - 2018 - Clinical Transplantation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/af759ccb-6d89-49d8-91ba-7d9a6427ec5e/ctr.2018.32.issue-9.cover.jpg)